| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-09 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-07 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-06 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0006 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0007 |